Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
45.16
-0.66 (-1.44%)
At close: May 01, 2025, 3:59 PM
44.99
-0.38%
After-hours: May 01, 2025, 04:27 PM EDT
Protagonist Therapeutics Revenue
Protagonist Therapeutics reported an annual revenue of $434.43M, reflecting a 624.05% growth. For the quarter ending December 31, 2024, Protagonist Therapeutics generated $170.64M in revenue.
Revenue (ttm)
$434.43M
Revenue Growth
624.05%
Price / Sales Ratio
5.47
Revenue / Employee
$3.45M
Employees
126
Market Cap
2.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 434.43M | +624.05% |
| Dec 31, 2023 | 60M | +125.73% |
| Dec 31, 2022 | 26.58M | -2.84% |
| Dec 31, 2021 | 27.36M | -4.44% |
| Dec 31, 2020 | 28.63M | n/a |